Earnings Call · Q4 FY2023·2023-04-27

Q2 23EPS +33.33%·Rev n/aQ1 23EPS -100.00%*·Rev n/aQ3 22EPS -100.00%*·Rev n/aQ2 22EPS +33.33%·Rev n/a⚠ consensus missing

Camp4 Therapeutics Corp CAMP

Joel Achramowicz — Managing Director of Shelton Group, Investor Relations

Jeff Gardner — President and Chief Executive Officer

Jikun Kim — Chief Financial Officer

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CAMP calls or request research access.

More CAMP calls Browse calls Request research access